RIM
Ranger Investment Management’s ANI Pharmaceuticals ANIP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.9M | Sell |
534,233
-37,405
| -7% | -$2.44M | 2.43% | 7 |
|
|
2025
Q1 | $38.3M | Sell |
571,638
-6,100
| -1% | -$408K | 2.74% | 8 |
|
|
2024
Q4 | $31.9M | Sell |
577,738
-11,950
| -2% | -$661K | 2.02% | 16 |
|
|
2024
Q3 | $35.2M | Buy |
589,688
+186,954
| +46% | +$11.2M | 2.26% | 11 |
|
|
2024
Q2 | $25.6M | Buy |
402,734
+530
| +0.1% | +$33.8K | 1.74% | 24 |
|
|
2024
Q1 | $27.8M | Sell |
402,204
-32,413
| -7% | -$2.24M | 1.79% | 23 |
|
|
2023
Q4 | $24M | Buy |
434,617
+7,769
| +2% | +$428K | 1.45% | 37 |
|
|
2023
Q3 | $24.8M | Sell |
426,848
-18,309
| -4% | -$1.06M | 1.65% | 25 |
|
|
2023
Q2 | $24M | Buy |
445,157
+319,601
| +255% | +$17.2M | 1.44% | 34 |
|
|
2023
Q1 | $4.99M | Buy |
125,556
+4,370
| +4% | +$174K | 0.33% | 60 |
|
|
2022
Q4 | $4.88M | Buy |
121,186
+2,676
| +2% | +$108K | 0.36% | 66 |
|
|
2022
Q3 | $3.81M | Sell |
118,510
-2,131
| -2% | -$68.5K | 0.3% | 69 |
|
|
2022
Q2 | $3.58M | Buy |
120,641
+2,840
| +2% | +$84.3K | 0.27% | 68 |
|
|
2022
Q1 | $3.31M | Buy |
117,801
+7,050
| +6% | +$198K | 0.21% | 70 |
|
|
2021
Q4 | $5.1M | Buy |
110,751
+25
| +0% | +$1.15K | 0.28% | 64 |
|
|
2021
Q3 | $3.63M | Buy |
110,726
+5,785
| +6% | +$190K | 0.19% | 76 |
|
|
2021
Q2 | $3.68M | Sell |
104,941
-440
| -0.4% | -$15.4K | 0.19% | 74 |
|
|
2021
Q1 | $3.81M | Sell |
105,381
-1,421
| -1% | -$51.3K | 0.21% | 76 |
|
|
2020
Q4 | $3.1M | Sell |
106,802
-17,961
| -14% | -$522K | 0.16% | 72 |
|
|
2020
Q3 | $3.52M | Buy |
124,763
+55,527
| +80% | +$1.57M | 0.22% | 64 |
|
|
2020
Q2 | $2.24M | Sell |
69,236
-27,875
| -29% | -$901K | 0.15% | 71 |
|
|
2020
Q1 | $3.96M | Buy |
97,111
+6,772
| +7% | +$276K | 0.35% | 57 |
|
|
2019
Q4 | $5.57M | Sell |
90,339
-3,325
| -4% | -$205K | 0.37% | 56 |
|
|
2019
Q3 | $6.83M | Buy |
93,664
+3,524
| +4% | +$257K | 0.49% | 52 |
|
|
2019
Q2 | $7.41M | Buy |
90,140
+3,623
| +4% | +$298K | 0.51% | 50 |
|
|
2019
Q1 | $6.1M | Buy |
86,517
+6,665
| +8% | +$470K | 0.44% | 53 |
|
|
2018
Q4 | $3.6M | Buy |
79,852
+9,640
| +14% | +$434K | 0.29% | 66 |
|
|
2018
Q3 | $3.97M | Buy |
70,212
+10,212
| +17% | +$577K | 0.26% | 60 |
|
|
2018
Q2 | $4.01M | Buy |
60,000
+10,783
| +22% | +$720K | 0.28% | 57 |
|
|
2018
Q1 | $2.87M | Buy |
49,217
+9,730
| +25% | +$566K | 0.21% | 63 |
|
|
2017
Q4 | $2.55M | Buy |
39,487
+2,593
| +7% | +$167K | 0.19% | 62 |
|
|
2017
Q3 | $1.94M | Buy |
36,894
+14,280
| +63% | +$750K | 0.15% | 63 |
|
|
2017
Q2 | $1.06M | Buy |
22,614
+7,084
| +46% | +$331K | 0.08% | 82 |
|
|
2017
Q1 | $769K | Buy |
+15,530
| New | +$769K | 0.06% | 86 |
|